Dr. Barry Dworkin

Tamoxifen shown to reduce breast cancer recurrence for women with early stage disease

Madely Health Headlines Commentary for August 2, 2011

Source:

Tamoxifen Legacy Lasts Long Term

Reference:

Early Breast Cancer Trialists’ Collaborative Group “Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials” Lancet 2011; DOI: 10.1016/S0140-6736(11)60993-8.

Related posts:

  1. Paxil interferes with tamoxifen's efficacy combating breast cancer/Sunday House Call returns to the airwaves
  2. Estrogen-sensitive breast cancer risk reduction study finds two drugs that work but have trade-offs
  3. Breast cancer risk from hormone replacement needs perspective when compared to other contributing factors
  4. More information needed about woman's breast cancer before slamming Ontario Government for not covering breast-cancer drug